The Atlantic Coast Retina Club (ACRC) Meeting and Macula 2023 returned to Boston last week for three days of events at Mass Eye and Ear and the Seaport Hotel. More than 300 people attended from across the country.... Read more about Atlantic Coast Retina Club/Macula 2023 a Great Success
Ivana K. Kim, MD, Associate Professor of Ophthalmology at Harvard Medical School and Director of the Macular Degeneration Unit and Co-Director of the Ocular Melanoma Center, was selected to present the Paul Henkind Memorial Lecture at the Macula Society 2022 annual meeting in June.... Read more about Ivana Kim, MD, to Present Paul Henkind Memorial Lecture
This year's Iraty Award for Research in Retinal Diseases honors Petr Baranov, PhD, a scientist at Schepens Eye Research Institute of Mass. Eye and Ear and Assistant Professor of Ophthalmology...
The Atlantic Coast Retina Club (ACRC) Meeting and Macula 2019 Conference was held at Mass. Eye and Ear and the Seaport Hotel on January 10-12.... Read more about ACRC/Macula 2019 a Success
Boston, Mass. — Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval gene therapy for patients with a form of inherited blindness. The occasion marks the beginning of a new era in medicine, as it is the first time any FDA-approved gene therapy has been given to a patient for any inherited disease.
The treatment, commercially identified as Luxturna, was developed by Spark Therapeutics and ...